$81.60
0.28% day before yesterday
NYSE, Sep 06, 10:10 pm CET
ISIN
US1011371077
Symbol
BSX

Boston Scientific Stock price

$81.60
+7.84 10.63% 1M
+14.18 21.03% 6M
+23.79 41.15% YTD
+27.74 51.50% 1Y
+36.68 81.66% 3Y
+38.15 87.80% 5Y
+69.28 562.34% 10Y
NYSE, Closing price Fri, Sep 06 2024
+0.23 0.28%
ISIN
US1011371077
Symbol
BSX
Sector

Key metrics

Market capitalization $120.17b
Enterprise Value $128.35b
P/E (TTM) P/E ratio 66.02
EV/FCF (TTM) EV/FCF 69.72
EV/Sales (TTM) EV/Sales 8.43
P/S ratio (TTM) P/S ratio 7.89
P/B ratio (TTM) P/B ratio 5.89
Revenue growth (TTM) Revenue growth 13.64%
Revenue (TTM) Revenue $15.23b
EBIT (operating result TTM) EBIT $2.51b
Free Cash Flow (TTM) Free Cash Flow $1.84b
Cash position $2.99b
EPS (TTM) EPS $1.24
P/E forward 59.32
P/S forward 7.38
EV/Sales forward 7.88
Short interest 0.73%
Show more

Is Boston Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Boston Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

35 Analysts have issued a Boston Scientific forecast:

30x Buy
86%
5x Hold
14%

Analyst Opinions

35 Analysts have issued a Boston Scientific forecast:

Buy
86%
Hold
14%

Financial data from Boston Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
15,228 15,228
14% 14%
100%
- Direct Costs 5,780 5,780
12% 12%
38%
9,448 9,448
15% 15%
62%
- Selling and Administrative Expenses 4,244 4,244
14% 14%
28%
- Research and Development Expense 1,468 1,468
8% 8%
10%
3,736 3,736
19% 19%
25%
- Depreciation and Amortization 1,229 1,229
6% 6%
8%
EBIT (Operating Income) EBIT 2,507 2,507
27% 27%
16%
Net Profit 1,826 1,826
100% 100%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Boston Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Boston Scientific Stock News

Neutral
Seeking Alpha
3 days ago
Boston Scientific Corporation (NYSE:BSX ) Wells Fargo 2024 Healthcare Conference September 4, 2024 8:00 AM ET Company Participants Brad Sutton - Chief Medical Officer, AF Solutions Jon Monson - SVP, IR Michael F. Mahoney - Chairman and CEO Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Lawrence Biegelsen Okay.
Neutral
FXEmpire
4 days ago
Medical device maker Boston Scientific Corporation (BSX) shares rising on product, financial performance.
Neutral
PRNewsWire
12 days ago
MARLBOROUGH, Mass. , Aug. 27, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has obtained CE mark for the ACURATE Prime™ Aortic Valve System, the newest transcatheter aortic valve replacement (TAVR) technology in the company's structural heart portfolio.
More Boston Scientific News

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Head office United States
CEO Michael Mahoney
Employees 48,000
Founded 1979
Website www.bostonscientific.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today